364 related articles for article (PubMed ID: 9500751)
1. Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.
Kemp JP; Cook DA; Incaudo GA; Corren J; Kalberg C; Emmett A; Cox FM; Rickard K
J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):188-95. PubMed ID: 9500751
[TBL] [Abstract][Full Text] [Related]
2. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
5. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
Busse W; Nelson H; Wolfe J; Kalberg C; Yancey SW; Rickard KA
J Allergy Clin Immunol; 1999 Jun; 103(6):1075-80. PubMed ID: 10359889
[TBL] [Abstract][Full Text] [Related]
6. A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: a Canadian multicenter study.
Boulet LP; Laviolette M; Boucher S; Knight A; Hébert J; Chapman KR
J Allergy Clin Immunol; 1997 Jan; 99(1 Pt 1):13-21. PubMed ID: 9003206
[TBL] [Abstract][Full Text] [Related]
7. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
Fish JE; Israel E; Murray JJ; Emmett A; Boone R; Yancey SW; Rickard KA
Chest; 2001 Aug; 120(2):423-30. PubMed ID: 11502639
[TBL] [Abstract][Full Text] [Related]
8. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
9. Salmeterol xinafoate in children on high dose inhaled steroids.
Russell G; Williams DA; Weller P; Price JF
Ann Allergy Asthma Immunol; 1995 Nov; 75(5):423-8. PubMed ID: 7583864
[TBL] [Abstract][Full Text] [Related]
10. Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.
Boonsawat W; Goryachkina L; Jacques L; Frith L
Clin Drug Investig; 2008; 28(2):101-11. PubMed ID: 18211118
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.
Wenzel SE; Lumry W; Manning M; Kalberg C; Cox F; Emmett A; Rickard K
Ann Allergy Asthma Immunol; 1998 Jun; 80(6):463-70. PubMed ID: 9647268
[TBL] [Abstract][Full Text] [Related]
12. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial.
Lazarus SC; Boushey HA; Fahy JV; Chinchilli VM; Lemanske RF; Sorkness CA; Kraft M; Fish JE; Peters SP; Craig T; Drazen JM; Ford JG; Israel E; Martin RJ; Mauger EA; Nachman SA; Spahn JD; Szefler SJ;
JAMA; 2001 May 23-30; 285(20):2583-93. PubMed ID: 11368732
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
Busse WW; Casale TB; Murray JJ; Petrocella V; Cox F; Rickard K
Am J Manag Care; 1998 Nov; 4(11):1579-87. PubMed ID: 10338904
[TBL] [Abstract][Full Text] [Related]
14. Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics.
Nielsen LP; Pedersen B; Faurschou P; Madsen F; Wilcke JT; Dahl R
Respir Med; 1999 Dec; 93(12):863-8. PubMed ID: 10653047
[TBL] [Abstract][Full Text] [Related]
15. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
Kalra S; Swystun VA; Bhagat R; Cockcroft DW
Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
[TBL] [Abstract][Full Text] [Related]
16. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
Boyd G
Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
[TBL] [Abstract][Full Text] [Related]
17. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M
Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220
[TBL] [Abstract][Full Text] [Related]
18. Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes.
Lockey RF; DuBuske LM; Friedman B; Petrocella V; Cox F; Rickard K
Chest; 1999 Mar; 115(3):666-73. PubMed ID: 10084473
[TBL] [Abstract][Full Text] [Related]
19. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
[TBL] [Abstract][Full Text] [Related]
20. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
